{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T01:55:36Z","timestamp":1788573336058,"version":"build-2803163510"},"reference-count":149,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2019,5,14]],"date-time":"2019-05-14T00:00:00Z","timestamp":1557792000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,5,14]],"date-time":"2019-05-14T00:00:00Z","timestamp":1557792000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Res"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1038\/s41390-019-0425-5","type":"journal-article","created":{"date-parts":[[2019,5,14]],"date-time":"2019-05-14T11:03:54Z","timestamp":1557831834000},"page":"265-276","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":60,"title":["Stem cell therapy for preventing neonatal diseases in the 21st century: Current understanding and challenges"],"prefix":"10.1038","volume":"87","author":[{"given":"Christopher R.","family":"Nitkin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johnson","family":"Rajasingh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Courtney","family":"Pisano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gail E.","family":"Besner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernard","family":"Th\u00e9baud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Venkatesh","family":"Sampath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,5,14]]},"reference":[{"key":"425_CR1","unstructured":"Kochanek, K. D., Murphy, S. L., Xu, J., Arias, E. Mortality in the United States, 2016. NCHS Data Brief, no 293. [Internet]. Hyattsville, MD: 2017. Available from: https:\/\/www.cdc.gov\/nchs\/products\/databriefs\/db293.htm ."},{"key":"425_CR2","unstructured":"Nitkin, C. R., Bonfield, T. L. Concise Review: Mesenchymal Stem Cell Therapy for Pediatric Disease: Perspectives on Success and Potential Improvements. Stem Cells Transl Med 2016 (cited 20 Sep 2016) Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27625040 ."},{"key":"425_CR3","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1038\/35070587","volume":"410","author":"D Orlic","year":"2001","unstructured":"Orlic, D. et al. Bone marrow cells regenerate infarcted myocardium. Nature 410, 701\u2013705, http:\/\/www.nature.com\/articles\/35070587 (2001).","journal-title":"Nature"},{"key":"425_CR4","first-page":"267","volume":"4","author":"AJ Friedenstein","year":"1976","unstructured":"Friedenstein, A. J., Gorskaja, J. F. & Kulagina, N. N. Fibroblast precursors in normal and irradiated mouse hematopoietic organs. Exp. Hematol. 4, 267\u2013274, http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/976387 (1976).","journal-title":"Exp. Hematol."},{"key":"425_CR5","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1634\/stemcells.2005-0342","volume":"24","author":"S Kern","year":"2006","unstructured":"Kern, S., Eichler, H., Stoeve, J., Kl\u00fcter, H. & Bieback, K. Comparative analysis of mesenchymal stem cells from bone marrow, umbilical cord blood, or adipose tissue. Stem Cells 24, 1294\u20131301, http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/16410387 (2006).","journal-title":"Stem Cells"},{"key":"425_CR6","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/j.cellbi.2006.03.009","volume":"30","author":"Z Miao","year":"2006","unstructured":"Miao, Z. et al. Isolation of mesenchymal stem cells from human placenta: comparison with human bone marrow mesenchymal stem cells. Cell Biol. Int. 30, 681\u2013687, http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/16870478 (2006).","journal-title":"Cell Biol. Int."},{"issue":"4","key":"425_CR7","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1080\/14653240600855905","volume":"8","author":"M. Dominici","year":"2006","unstructured":"Dominici, M., et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 2006 8:315\u2013317.","journal-title":"Cytotherapy"},{"key":"425_CR8","doi-asserted-by":"crossref","first-page":"2606","DOI":"10.1089\/scd.2013.0016","volume":"22","author":"H Wegmeyer","year":"2013","unstructured":"Wegmeyer, H. et al. Mesenchymal stromal cell characteristics vary depending on their origin. Stem Cells Dev. 22, 2606\u20132618 (2013).","journal-title":"Stem Cells Dev."},{"key":"425_CR9","doi-asserted-by":"crossref","first-page":"2565","DOI":"10.1002\/term.2153","volume":"11","author":"A Hoffmann","year":"2017","unstructured":"Hoffmann, A., Floerkemeier, T., Melzer, C. & Hass, R. Comparison of in vitro-cultivation of human mesenchymal stroma\/stem cells derived from bone marrow and umbilical cord. J. Tissue Eng. Regen. Med. 11, 2565\u20132581 (2017).","journal-title":"J. Tissue Eng. Regen. Med."},{"key":"425_CR10","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1038\/bmt.2011.81","volume":"47","author":"ME Bernardo","year":"2012","unstructured":"Bernardo, M. E., Pagliara, D. & Locatelli, F. Mesenchymal stromal cell therapy: a revolution in Regenerative Medicine? Bone Marrow Transpl. 47, 164\u2013171 (2012).","journal-title":"Bone Marrow Transpl."},{"key":"425_CR11","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1177\/0271678X18776802","volume":"38","author":"CJ Cunningham","year":"2018","unstructured":"Cunningham, C. J., Redondo-Castro, E. & Allan, S. M. The therapeutic potential of the mesenchymal stem cell secretome in ischaemic stroke. J. Cereb. Blood Flow. Metab. 38, 1276\u20131292 (2018).","journal-title":"J. Cereb. Blood Flow. Metab."},{"key":"425_CR12","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1002\/ppul.22791","volume":"48","author":"D Grisafi","year":"2013","unstructured":"Grisafi, D. et al. Human amniotic fluid stem cells protect rat lungs exposed to moderate hyperoxia. Pedia. Pulmonol. 48, 1070\u20131080 (2013).","journal-title":"Pedia. Pulmonol."},{"key":"425_CR13","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1016\/j.jpedsurg.2018.02.086","volume":"53","author":"CJ McCulloh","year":"2018","unstructured":"McCulloh, C. J. et al. Treatment of experimental necrotizing enterocolitis with stem cell-derived exosomes. J. Pedia. Surg. 53, 1215\u20131220 (2018).","journal-title":"J. Pedia. Surg."},{"key":"425_CR14","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1002\/pd.4621","volume":"35","author":"P Dekoninck","year":"2015","unstructured":"Dekoninck, P. et al. The use of human amniotic fluid stem cells as an adjunct to promote pulmonary development in a rabbit model for congenital diaphragmatic hernia. Prenat. Diagn. 35, 833\u2013840 (2015).","journal-title":"Prenat. Diagn."},{"key":"425_CR15","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1136\/gutjnl-2012-303735","volume":"63","author":"A Zani","year":"2014","unstructured":"Zani, A. et al. Amniotic fluid stem cells improve survival and enhance repair of damaged intestine in necrotising enterocolitis via a COX-2 dependent mechanism. Gut 63, 300\u2013309 (2014).","journal-title":"Gut"},{"key":"425_CR16","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1089\/scd.2014.0265","volume":"24","author":"T Erkers","year":"2015","unstructured":"Erkers, T. et al. Treatment of severe chronic graft-versus-host disease with decidual stromal cells and tracing with (111)indium radiolabeling. Stem Cells Dev. 24, 253\u2013263 (2015).","journal-title":"Stem Cells Dev."},{"key":"425_CR17","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1016\/j.athoracsur.2017.04.058","volume":"104","author":"B Wehman","year":"2017","unstructured":"Wehman, B. et al. Cardiac progenitor cells enhance neonatal right ventricular function after pulmonary artery banding. Ann. Thorac. Surg. 104, 2045\u20132053 (2017).","journal-title":"Ann. Thorac. Surg."},{"key":"425_CR18","doi-asserted-by":"crossref","first-page":"e002043","DOI":"10.1161\/JAHA.115.002043","volume":"4","author":"E Avolio","year":"2015","unstructured":"Avolio, E. et al. Expansion and characterization of neonatal cardiac pericytes provides a novel cellular option for tissue engineering in congenital heart disease. J. Am. Heart Assoc. 4, e002043 (2015).","journal-title":"J. Am. Heart Assoc."},{"key":"425_CR19","volume":"7","author":"K Nakanishi","year":"2017","unstructured":"Nakanishi, K. et al. Rat umbilical cord blood cells attenuate hypoxic\u2013ischemic brain injury in neonatal rats. Sci. Rep. 7, 44111 (2017).","journal-title":"Sci. Rep."},{"key":"425_CR20","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1159\/000374107","volume":"37","author":"A Drobyshevsky","year":"2015","unstructured":"Drobyshevsky, A. et al. Human umbilical cord blood cells ameliorate motor deficits in rabbits in a cerebral palsy model. Dev. Neurosci. 37, 349\u2013362 (2015).","journal-title":"Dev. Neurosci."},{"key":"425_CR21","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.lfs.2013.10.017","volume":"96","author":"S Greggio","year":"2014","unstructured":"Greggio, S., De Paula, S., Azevedo, P. N., Venturin, G. T. & Dacosta, J. C. Intra-arterial transplantation of human umbilical cord blood mononuclear cells in neonatal hypoxic-ischemic rats. Life Sci. 96, 33\u201339 (2014).","journal-title":"Life Sci."},{"key":"425_CR22","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/j.athoracsur.2015.04.130","volume":"100","author":"CP Brizard","year":"2015","unstructured":"Brizard, C. P. et al. Safety of intracoronary human cord blood stem cells in a lamb model of infant cardiopulmonary bypass. Ann. Thorac. Surg. 100, 1021\u20131029 (2015).","journal-title":"Ann. Thorac. Surg."},{"key":"425_CR23","doi-asserted-by":"crossref","first-page":"2190","DOI":"10.1111\/j.1582-4934.2010.01151.x","volume":"14","author":"DJ Prockop","year":"2010","unstructured":"Prockop, D. J., Kota, D. J., Bazhanov, N. & Reger, R. L. Evolving paradigms for repair of tissues by adult stem\/progenitor cells (MSCs). J. Cell Mol. Med. 14, 2190\u20132199 (2010).","journal-title":"J. Cell Mol. Med."},{"key":"425_CR24","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1038\/pr.2013.176","volume":"75","author":"ME Fung","year":"2014","unstructured":"Fung, M. E. & Th\u00e9baud, B. Stem cell-based therapy for neonatal lung disease: it is in the juice. Pediatr. Res. 75, 2\u20137 (2014).","journal-title":"Pediatr. Res."},{"key":"425_CR25","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1002\/stem.643","volume":"29","author":"JW Lee","year":"2011","unstructured":"Lee, J. W., Fang, X., Krasnodembskaya, A., Howard, J. P. & Matthay, M. A. Concise review: Mesenchymal stem cells for acute lung injury: role of paracrine soluble factors. Stem Cells 29, 913\u2013919 (2011).","journal-title":"Stem Cells"},{"key":"425_CR26","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1002\/sctm.17-0126","volume":"6","author":"S Augustine","year":"2017","unstructured":"Augustine, S. et al. Mesenchymal stromal cell therapy in bronchopulmonary dysplasia: systematic review and meta-analysis of preclinical studies. Stem Cells Transl. Med. 6, 2079\u20132093 (2017).","journal-title":"Stem Cells Transl. Med."},{"key":"425_CR27","doi-asserted-by":"crossref","first-page":"11002","DOI":"10.1073\/pnas.0704421104","volume":"104","author":"LA Ortiz","year":"2007","unstructured":"Ortiz, L. A. et al. Interleukin 1 receptor antagonist mediates the antiinflammatory and antifibrotic effect of mesenchymal stem cells during lung injury. Proc. Natl Acad. Sci. USA 104, 11002\u201311007 (2007).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"425_CR28","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1186\/s13287-018-0903-4","volume":"9","author":"S Chaubey","year":"2018","unstructured":"Chaubey, S. et al. Early gestational mesenchymal stem cell secretome attenuates experimental bronchopulmonary dysplasia in part via exosome-associated factor TSG-6. Stem Cell Res Ther. 9, 173 (2018).","journal-title":"Stem Cell Res Ther."},{"key":"425_CR29","doi-asserted-by":"crossref","first-page":"13724","DOI":"10.1073\/pnas.1008117107","volume":"107","author":"TJ Bartosh","year":"2010","unstructured":"Bartosh, T. J. et al. Aggregation of human mesenchymal stromal cells (MSCs) into 3D spheroids enhances their antiinflammatory properties. Proc. Natl Acad. Sci. USA 107, 13724\u201313729 (2010).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"425_CR30","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1038\/nm.1905","volume":"15","author":"K N\u00e9meth","year":"2009","unstructured":"N\u00e9meth, K. et al. Bone marrow stromal cells attenuate sepsis via prostaglandin E(2)-dependent reprogramming of host macrophages to increase their interleukin-10 production. Nat. Med. 15, 42\u201349 (2009).","journal-title":"Nat. Med."},{"key":"425_CR31","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1038\/mt.2014.217","volume":"23","author":"M Ono","year":"2015","unstructured":"Ono, M. et al. Mesenchymal stem cells correct inappropriate epithelial-mesenchyme relation in pulmonary fibrosis using stanniocalcin-1. Mol. Ther. 23, 549\u2013560 (2015).","journal-title":"Mol. Ther."},{"key":"425_CR32","first-page":"1437","volume":"17","author":"LL Li","year":"2018","unstructured":"Li, L. L. et al. Mesenchymal stem cells overexpressing adrenomedullin improve heart function through antifibrotic action in rats experiencing heart failure. Mol. Med Rep. 17, 1437\u20131444 (2018).","journal-title":"Mol. Med Rep."},{"key":"425_CR33","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.mehy.2008.03.046","volume":"71","author":"YX Xu","year":"2008","unstructured":"Xu, Y.-X. et al. Mesenchymal stem cell therapy for diabetes through paracrine mechanisms. Med. Hypotheses 71, 390\u2013393 (2008).","journal-title":"Med. Hypotheses"},{"key":"425_CR34","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1165\/rcmb.2013-0385OC","volume":"51","author":"YS Chang","year":"2014","unstructured":"Chang, Y. S. et al. Critical role of vascular endothelial growth factor secreted by mesenchymal stem cells in hyperoxic lung injury. Am. J. Respir. Cell Mol. Biol. 51, 391\u2013399 (2014).","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"425_CR35","doi-asserted-by":"crossref","first-page":"16357","DOI":"10.1073\/pnas.0907996106","volume":"106","author":"JW Lee","year":"2009","unstructured":"Lee, J. W., Fang, X., Matthay, M. A., Serikov, V., Gupta, N. Allogeneic human mesenchymal stem cells for treatment of E. coli endotoxin-induced acute lung injury in the ex vivo perfused human lung. Proc. Natl Acad. Sci. USA 106, 16357\u201316362 (2009).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"425_CR36","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1093\/jb\/mvj128","volume":"140","author":"G van Niel","year":"2006","unstructured":"van Niel, G., Porto-Carreiro, I., Simoes, S. & Raposo, G. Exosomes: a common pathway for a specialized function. J. Biochem. 140, 13\u201321 (2006).","journal-title":"J. Biochem."},{"key":"425_CR37","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1182\/blood-2011-11-389478","volume":"119","author":"W Stoorvogel","year":"2012","unstructured":"Stoorvogel, W. Functional transfer of microRNA by exosomes. Blood 119, 646\u2013648 (2012).","journal-title":"Blood"},{"key":"425_CR38","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1164\/rccm.200902-0179OC","volume":"180","author":"T van Haaften","year":"2009","unstructured":"van Haaften, T. et al. Airway delivery of mesenchymal stem cells prevents arrested alveolar growth in neonatal lung injury in rats. Am. J. Respir. Crit. Care Med. 180, 1131\u20131142 (2009).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"425_CR39","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1164\/rccm.200902-0242OC","volume":"180","author":"M Aslam","year":"2009","unstructured":"Aslam, M. et al. Bone marrow stromal cells attenuate lung injury in a murine model of neonatal chronic lung disease. Am. J. Respir. Crit. Care Med. 180, 1122\u20131130 (2009).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"425_CR40","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1136\/thoraxjnl-2012-202323","volume":"68","author":"M Pierro","year":"2013","unstructured":"Pierro, M. et al. Short-term, long-term and paracrine effect of human umbilical cord-derived stem cells in lung injury prevention and repair in experimental bronchopulmonary dysplasia. Thorax 68, 475\u2013484 (2013).","journal-title":"Thorax"},{"key":"425_CR41","doi-asserted-by":"crossref","first-page":"2789","DOI":"10.1089\/scd.2010.0566","volume":"21","author":"P Waszak","year":"2012","unstructured":"Waszak, P. et al. Preconditioning enhances the paracrine effect of mesenchymal stem cells in preventing oxygen-induced neonatal lung injury in rats. Stem Cells Dev. 21, 2789\u20132797 (2012).","journal-title":"Stem Cells Dev."},{"issue":"9","key":"425_CR42","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.3390\/ijms18091852","volume":"18","author":"Francisco Vizoso","year":"2017","unstructured":"Vizoso, F. J., Eiro, N., Cid, S., Schneider, J., Perez-Fernandez, R. Mesenchymal stem cell secretome: toward cell-free therapeutic strategies in regenerative medicine. Int. J. Mol. Sci. 18, 1852 (2017). Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/28841158 .","journal-title":"International Journal of Molecular Sciences"},{"key":"425_CR43","doi-asserted-by":"crossref","first-page":"251","DOI":"10.5487\/TR.2016.32.3.251","volume":"32","author":"SJ Park","year":"2016","unstructured":"Park, S.-J. et al. Tumorigenicity evaluation of umbilical cord blood-derived mesenchymal stem cells. Toxicol. Res. 32, 251\u2013258 (2016).","journal-title":"Toxicol. Res."},{"key":"425_CR44","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/j.jcyt.2013.03.005","volume":"15","author":"L Barkholt","year":"2013","unstructured":"Barkholt, L. et al. Risk of tumorigenicity in mesenchymal stromal cell-based therapies - Bridging scientific observations and regulatory viewpoints. Cytotherapy 15, 753\u2013759 (2013).","journal-title":"Cytotherapy"},{"issue":"6","key":"425_CR45","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1089\/scd.2017.0248","volume":"27","author":"Shiva Hamidian Jahromi","year":"2018","unstructured":"Hamidian, Jahromi, S., Estrada, C., Li, Y., Cheng, E., Davies, J. E. Human umbilical cord perivascular cells and human bone marrow mesenchymal stromal cells transplanted intramuscularly respond to a distant source of inflammation. Stem Cells Dev. 2018;27:scd.2017.0248. Available from: https:\/\/doi.org\/10.1089\/scd.2017.0248 .","journal-title":"Stem Cells and Development"},{"key":"425_CR46","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.3892\/mmr.2014.2959","volume":"11","author":"Y Luan","year":"2015","unstructured":"Luan, Y. et al. Bone marrow-derived mesenchymal stem cells protect against lung injury in a mouse model of bronchopulmonary dysplasia. Mol. Med. Rep. 11, 1945\u20131950 (2015).","journal-title":"Mol. Med. Rep."},{"key":"425_CR47","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/j.nucmedbio.2011.03.008","volume":"38","author":"A Gholamrezanezhad","year":"2011","unstructured":"Gholamrezanezhad, A. et al. In vivo tracking of 111In-oxine labeled mesenchymal stem cells following infusion in patients with advanced cirrhosis. Nucl. Med. Biol. 38, 961\u2013967 (2011).","journal-title":"Nucl. Med. Biol."},{"key":"425_CR48","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1002\/jnr.23304","volume":"92","author":"X Zhang","year":"2014","unstructured":"Zhang, X. et al. Therapeutic effect of human umbilical cord mesenchymal stem cells on neonatal rat hypoxic-ischemic encephalopathy. J. Neurosci. Res 92, 35\u201345 (2014).","journal-title":"J. Neurosci. Res"},{"key":"425_CR49","doi-asserted-by":"crossref","first-page":"133","DOI":"10.3389\/fneur.2018.00133","volume":"9","author":"E Tanaka","year":"2018","unstructured":"Tanaka, E. et al. Dose-dependent effect of intravenous administration of human umbilical cord-derived mesenchymal stem cells in neonatal stroke mice. Front Neurol. 9, 133 (2018).","journal-title":"Front Neurol."},{"key":"425_CR50","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1038\/pr.2015.145","volume":"78","author":"V Donega","year":"2015","unstructured":"Donega, V. et al. Assessment of long-term safety and efficacy of intranasal mesenchymal stem cell treatment for neonatal brain injury in the mouse. Pediatr. Res. 78, 520\u2013526 (2015).","journal-title":"Pediatr. Res."},{"key":"425_CR51","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.expneurol.2014.06.009","volume":"261","author":"V Donega","year":"2014","unstructured":"Donega, V. et al. Intranasally administered mesenchymal stem cells promote a regenerative niche for repair of neonatal ischemic brain injury. Exp. Neurol. 261, 53\u201364 (2014).","journal-title":"Exp. Neurol."},{"key":"425_CR52","doi-asserted-by":"crossref","first-page":"17","DOI":"10.3727\/215517913X658936","volume":"5","author":"D Park","year":"2013","unstructured":"Park, D. et al. Transplantation of human adipose tissue-derived mesenchymal stem cells restores the neurobehavioral disorders of rats with neonatal hypoxic-ischemic encephalopathy. Cell Med. 5, 17\u201328 (2013).","journal-title":"Cell Med."},{"key":"425_CR53","first-page":"342","volume":"8","author":"HC Chou","year":"2016","unstructured":"Chou, H. C., Li, Y. T. & Chen, C. M. Human mesenchymal stem cells attenuate experimental bronchopulmonary dysplasia induced by perinatal inflammation and hyperoxia. Am. J. Transl. Res. 8, 342\u2013353 (2016).","journal-title":"Am. J. Transl. Res."},{"key":"425_CR54","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1038\/cmi.2015.99","volume":"14","author":"H Ding","year":"2017","unstructured":"Ding, H. et al. Transplantation of placenta-derived mesenchymal stem cells reduces hypoxic-ischemic brain damage in rats by ameliorating the inflammatory response. Cell Mol. Immunol. 14, 693\u2013701 (2017).","journal-title":"Cell Mol. Immunol."},{"key":"425_CR55","doi-asserted-by":"crossref","first-page":"e0164269","DOI":"10.1371\/journal.pone.0164269","volume":"11","author":"I Sammour","year":"2016","unstructured":"Sammour, I. et al. The effect of gender on mesenchymal stem cell (MSC) efficacy in neonatal hyperoxia-induced lung injury. PLoS ONE 11, e0164269 (2016).","journal-title":"PLoS ONE"},{"key":"425_CR56","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1164\/rccm.201705-0925OC","volume":"197","author":"GR Willis","year":"2018","unstructured":"Willis, G. R. et al. Mesenchymal stromal cell exosomes ameliorate experimental bronchopulmonary dysplasia and restore lung function through macrophage immunomodulation. Am. J. Respir. Crit. Care Med. 197, 104\u2013116 (2018).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"425_CR57","doi-asserted-by":"crossref","first-page":"2709","DOI":"10.1007\/s00018-015-1907-1","volume":"72","author":"N Woik","year":"2015","unstructured":"Woik, N. & Kroll, J. Regulation of lung development and regeneration by the vascular system. Cell Mol. Life Sci. 72, 2709\u20132718 (2015).","journal-title":"Cell Mol. Life Sci."},{"key":"425_CR58","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ejcb.2016.04.003","volume":"95","author":"T Montemurro","year":"2016","unstructured":"Montemurro, T. et al. Angiogenic and anti-inflammatory properties of mesenchymal stem cells from cord blood: soluble factors and extracellular vesicles for cell regeneration. Eur. J. Cell Biol. 95, 228\u2013238 (2016).","journal-title":"Eur. J. Cell Biol."},{"key":"425_CR59","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1016\/j.tjog.2018.08.020","volume":"57","author":"YC Wen","year":"2018","unstructured":"Wen, Y.-C. et al. EphA2-positive human umbilical cord-derived mesenchymal stem cells exert anti-fibrosis and immunomodulatory activities via secretion of prostaglandin E2. Taiwan J. Obstet. Gynecol. 57, 722\u2013725 (2018).","journal-title":"Taiwan J. Obstet. Gynecol."},{"key":"425_CR60","doi-asserted-by":"crossref","first-page":"47082","DOI":"10.18632\/oncotarget.9314","volume":"7","author":"Y Luan","year":"2016","unstructured":"Luan, Y. et al. Mesenchymal stem cells in combination with erythropoietin repair hyperoxia-induced alveoli dysplasia injury in neonatal mice via inhibition of TGF-\u03b21 signaling. Oncotarget 7, 47082\u201347094 (2016).","journal-title":"Oncotarget"},{"key":"425_CR61","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1016\/j.bbrc.2017.12.055","volume":"495","author":"C Hou","year":"2018","unstructured":"Hou, C. et al. Human umbilical cord-derived mesenchymal stem cells protect from hyperoxic lung injury by ameliorating aberrant elastin remodeling in the lung of O2-exposed newborn rat. Biochem. Biophys. Res. Commun. 495, 1972\u20131979 (2018).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"425_CR62","doi-asserted-by":"crossref","first-page":"3344","DOI":"10.1016\/j.ajpath.2014.08.010","volume":"184","author":"L Liu","year":"2014","unstructured":"Liu, L. et al. Intranasal versus intraperitoneal delivery of human umbilical cord tissue\u2013derived cultured mesenchymal stromal cells in a murine model of neonatal lung injury. Am. J. Pathol. 184, 3344\u20133358 (2014).","journal-title":"Am. J. Pathol."},{"key":"425_CR63","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.3892\/mmr.2016.5378","volume":"14","author":"ZH Zhang","year":"2016","unstructured":"Zhang, Z.-H. et al. Protective effects of BMSCs in combination with erythropoietin in bronchopulmonary dysplasia-induced lung injury. Mol. Med Rep. 14, 1302\u20131308 (2016).","journal-title":"Mol. Med Rep."},{"key":"425_CR64","doi-asserted-by":"crossref","first-page":"H1816","DOI":"10.1152\/ajpheart.00955.2015","volume":"310","author":"B Wehman","year":"2016","unstructured":"Wehman, B. et al. Mesenchymal stem cells preserve neonatal right ventricular function in a porcine model of pressure overload. Am. J. Physiol. - Hear Circ. Physiol. 310, H1816\u2013H1826 (2016).","journal-title":"Am. J. Physiol. - Hear Circ. Physiol."},{"key":"425_CR65","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1053\/j.semperi.2018.09.006","volume":"42","author":"V Dumpa","year":"2018","unstructured":"Dumpa, V. & Bhandari, V. Surfactant, steroids and non-invasive ventilation in the prevention of BPD. Semin Perinatol. 42, 444\u2013452 (2018).","journal-title":"Semin Perinatol."},{"key":"425_CR66","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1165\/rcmb.2016-0006OC","volume":"55","author":"HL Menden","year":"2016","unstructured":"Menden, H. L. et al. Nicotinamide adenine dinucleotide phosphate oxidase 2 regulates LPS-induced inflammation and alveolar remodeling in the developing lung. Am. J. Respir. Cell Mol. Biol. 55, 767\u2013778 (2016).","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"425_CR67","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1053\/j.semperi.2018.09.001","volume":"42","author":"RE Morty","year":"2018","unstructured":"Morty, R. E. Recent advances in the pathogenesis of BPD. Semin Perinatol. 42, 404\u2013412 (2018).","journal-title":"Semin Perinatol."},{"key":"425_CR68","doi-asserted-by":"crossref","first-page":"e370","DOI":"10.2741\/1060","volume":"8","author":"A Bhandari","year":"2003","unstructured":"Bhandari, A. & Bhandari, V. Pathogenesis, pathology and pathophysiology of pulmonary sequelae of bronchopulmonary dysplasia in premature infants. Front Biosci. 8, e370\u2013e380 (2003).","journal-title":"Front Biosci."},{"key":"425_CR69","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1097\/MOP.0000000000000095","volume":"26","author":"CD Baker","year":"2014","unstructured":"Baker, C. D. & Alvira, C. M. Disrupted lung development and bronchopulmonary dysplasia. Curr. Opin. Pediatr. 26, 306\u2013314 (2014).","journal-title":"Curr. Opin. Pediatr."},{"key":"425_CR70","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1038\/s41390-018-0228-0","volume":"85","author":"M \u00c1lvarez-Fuente","year":"2019","unstructured":"\u00c1lvarez-Fuente, M. et al. Preventing bronchopulmonary dysplasia: new tools for an old challenge. Pediatr. Res 85, 432\u2013441 (2019).","journal-title":"Pediatr. Res"},{"key":"425_CR71","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1164\/ajrccm.163.7.2011060","volume":"163","author":"AH Jobe","year":"2001","unstructured":"Jobe, A. H. & Bancalari, E. Bronchopulmonary dysplasia. Am. J. Respir. Crit. Care Med 163, 1723\u20131729 (2001).","journal-title":"Am. J. Respir. Crit. Care Med"},{"key":"425_CR72","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1002\/sctm.17-0051","volume":"6","author":"AI Caplan","year":"2017","unstructured":"Caplan, A. I. Mesenchymal stem cells: time to change the name! Stem Cells Transl. Med. 6, 1445\u20131451 (2017).","journal-title":"Stem Cells Transl. Med."},{"key":"425_CR73","doi-asserted-by":"crossref","unstructured":"Fischbach, M. A., Bluestone, J. A., Lim, W. A. Cell-based therapeutics: the next pillar of medicine. Sci. Transl. Med. 2013","DOI":"10.1126\/scitranslmed.3005568"},{"key":"425_CR74","first-page":"CD011932","volume-title":"Cochrane Database Syst Rev.","author":"M Pierro","year":"2017","unstructured":"Pierro, M., Th\u00e9baud, B. & Soll, R. Mesenchymal stem cells for the prevention and treatment of bronchopulmonary dysplasia in preterm infants. Cochrane Database Syst Rev. 11, (CD011932 (2017)."},{"key":"425_CR75","doi-asserted-by":"crossref","first-page":"e52419","DOI":"10.1371\/journal.pone.0052419","volume":"8","author":"YS Chang","year":"2013","unstructured":"Chang, Y. S. et al. Timing of umbilical cord blood derived mesenchymal stem cells transplantation determines therapeutic efficacy in the neonatal hyperoxic lung injury. PLoS ONE 8, e52419 (2013).","journal-title":"PLoS ONE"},{"key":"425_CR76","doi-asserted-by":"crossref","first-page":"L6","DOI":"10.1152\/ajplung.00109.2018","volume":"316","author":"A Porzionato","year":"2019","unstructured":"Porzionato, A. et al. Intratracheal administration of clinical-grade mesenchymal stem cell-derived extracellular vesicles reduces lung injury in a rat model of bronchopulmonary dysplasia. Am. J. Physiol. Cell Mol. Physiol. 316, L6\u2013L19 (2019).","journal-title":"Am. J. Physiol. Cell Mol. Physiol."},{"key":"425_CR77","doi-asserted-by":"crossref","first-page":"e1000412","DOI":"10.1371\/journal.pbio.1000412","volume":"8","author":"C Kilkenny","year":"2010","unstructured":"Kilkenny, C., Browne, W. J., Cuthill, I. C., Emerson, M. & Altman, D. G. Improving bioscience research reporting: the ARRIVE guidelines for reporting animal research. PLoS Biol. 8, e1000412 (2010).","journal-title":"PLoS Biol."},{"key":"425_CR78","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1016\/j.jpeds.2013.12.011","volume":"164","author":"YS Chang","year":"2014","unstructured":"Chang, Y. S. et al. Mesenchymal stem cells for bronchopulmonary dysplasia: phase 1 dose-escalation clinical trial. J. Pediatr. 164, 966\u2013972.e6 (2014).","journal-title":"J. Pediatr."},{"key":"425_CR79","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.jpeds.2017.02.061","volume":"185","author":"SY Ahn","year":"2017","unstructured":"Ahn, S. Y., Chang, Y. S., Kim, J. H., Sung, S. I. & Park, W. S. Two-year follow-up outcomes of premature infants enrolled in the phase I trial of mesenchymal stem cells transplantation for bronchopulmonary dysplasia. J. Pediatr. 185, 49\u201354.e2 (2017).","journal-title":"J. Pediatr."},{"key":"425_CR80","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1001\/jamapediatrics.2014.3269","volume":"169","author":"M Douglas-Escobar","year":"2015","unstructured":"Douglas-Escobar, M. & Weiss, M. D. Hypoxic-ischemic encephalopathy: a review for the clinician. JAMA Pediatr. 169, 397\u2013403 (2015).","journal-title":"JAMA Pediatr."},{"key":"425_CR81","volume":"8","author":"Y Gu","year":"2015","unstructured":"Gu, Y. et al. Mesenchymal stem cells suppress neuronal apoptosis and decrease IL-10 release via the TLR2\/NF\u03baB pathway in rats with hypoxic-ischemic brain damage. Mol. Brain 8, 65 (2015).","journal-title":"Mol. Brain"},{"key":"425_CR82","doi-asserted-by":"crossref","first-page":"e0120893","DOI":"10.1371\/journal.pone.0120893","volume":"10","author":"WS Park","year":"2015","unstructured":"Park, W. S. et al. Hypothermia augments neuroprotective activity of mesenchymal stem cells for neonatal hypoxic-ischemic encephalopathy. PLoS ONE 10, e0120893 (2015).","journal-title":"PLoS ONE"},{"key":"425_CR83","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1089\/scd.2016.0108","volume":"26","author":"M Mueller","year":"2017","unstructured":"Mueller, M. et al. Wharton\u2019s jelly mesenchymal stem cells protect the immature brain in rats and modulate cell fate. Stem Cells Dev. 26, 239\u2013248 (2017).","journal-title":"Stem Cells Dev."},{"key":"425_CR84","doi-asserted-by":"crossref","first-page":"e112339","DOI":"10.1371\/journal.pone.0112339","volume":"9","author":"V Donega","year":"2014","unstructured":"Donega, V. et al. Intranasal administration of human MSC for ischemic brain injury in the mouse: In vitro and in vivo neuroregenerative functions. PLoS ONE 9, e112339 (2014).","journal-title":"PLoS ONE"},{"key":"425_CR85","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1002\/sctm.17-0074","volume":"6","author":"I Grandvuillemin","year":"2017","unstructured":"Grandvuillemin, I. et al. Long-term recovery after endothelial colony-forming cells or human umbilical cord blood cells administration in a rat model of neonatal hypoxic-ischemic encephalopathy. Stem Cells Transl. Med. 6, 1987\u20131996 (2017).","journal-title":"Stem Cells Transl. Med."},{"key":"425_CR86","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.expneurol.2016.06.017","volume":"283","author":"J Li","year":"2016","unstructured":"Li, J. et al. Preterm white matter brain injury is prevented by early administration of umbilical cord blood cells. Exp. Neurol. 283, 179\u2013187 (2016).","journal-title":"Exp. Neurol."},{"key":"425_CR87","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1038\/pr.2016.172","volume":"81","author":"L Braccioli","year":"2017","unstructured":"Braccioli, L., Heijnen, C. J., Coffer, P. J. & Nijboer, C. H. Delayed administration of neural stem cells after hypoxia-ischemia reduces sensorimotor deficits, cerebral lesion size, and neuroinflammation in neonatal mice. Pediatr. Res. 81, 127\u2013135 (2017).","journal-title":"Pediatr. Res."},{"key":"425_CR88","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/j.jpeds.2013.11.036","volume":"164","author":"CM Cotten","year":"2014","unstructured":"Cotten, C. M. et al. Feasibility of autologous cord blood cells for infants with hypoxic-ischemic encephalopathy. J. Pediatr. 164, 973\u2013979.e1 (2014).","journal-title":"J. Pediatr."},{"key":"425_CR89","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.5966\/sctm.2015-0372","volume":"5","author":"I Novak","year":"2016","unstructured":"Novak, I. et al. Concise review: stem cell interventions for people with cerebral palsy: systematic review with meta-analysis. Stem Cells Transl. Med. 5, 1014\u20131025 (2016).","journal-title":"Stem Cells Transl. Med."},{"key":"425_CR90","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1016\/j.jcyt.2013.06.001","volume":"15","author":"X Wang","year":"2013","unstructured":"Wang, X. et al. Effects of bone marrow mesenchymal stromal cells on gross motor function measure scores of children with cerebral palsy: a preliminary clinical study. Cytotherapy 15, 1549\u20131562 (2013).","journal-title":"Cytotherapy"},{"key":"425_CR91","doi-asserted-by":"crossref","first-page":"15","DOI":"10.3389\/fphys.2019.00015","volume":"10","author":"M Finch-Edmondson","year":"2019","unstructured":"Finch-Edmondson, M., Morgan, C., Hunt, R. W. & Novak, I. Emergent prophylactic, reparative and restorative brain interventions for infants born preterm with cerebral palsy. Front Physiol. 10, 15 (2019).","journal-title":"Front Physiol."},{"key":"425_CR92","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1161\/STROKEAHA.112.679092","volume":"44","author":"SY Ahn","year":"2013","unstructured":"Ahn, S. Y. et al. Mesenchymal stem cells prevent hydrocephalus after severe intraventricular hemorrhage. Stroke 44, 497\u2013504 (2013).","journal-title":"Stroke"},{"key":"425_CR93","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.brainres.2014.03.030","volume":"1563","author":"LH Zhu","year":"2014","unstructured":"Zhu, L. H. et al. Improvement of human umbilical cord mesenchymal stem cell transplantation on glial cell and behavioral function in a neonatal model of periventricular white matter damage. Brain Res 1563, 13\u201321 (2014).","journal-title":"Brain Res"},{"key":"425_CR94","doi-asserted-by":"crossref","first-page":"145","DOI":"10.3727\/096368916X692861","volume":"26","author":"SY Ahn","year":"2017","unstructured":"Ahn, S. Y. et al. Pivotal Role of Brain-Derived Neurotrophic Factor Secreted by Mesenchymal Stem Cells in Severe Intraventricular Hemorrhage in Newborn Rats. Cell Transpl. 26, 145\u2013156 (2017).","journal-title":"Cell Transpl."},{"key":"425_CR95","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s41232-016-0032-3","volume":"37","author":"C Morioka","year":"2017","unstructured":"Morioka, C. et al. Neuroprotective effects of human umbilical cord-derived mesenchymal stem cells on periventricular leukomalacia-like brain injury in neonatal rats. Inflamm. Regen. 37, 1 (2017).","journal-title":"Inflamm. Regen."},{"key":"425_CR96","doi-asserted-by":"crossref","first-page":"325652","DOI":"10.1155\/2015\/325652","volume":"2015","author":"M Feng","year":"2015","unstructured":"Feng, M. et al. Safety of Allogeneic Umbilical Cord Blood Stem Cells Therapy in Patients with Severe Cerebral Palsy: A Retrospective Study. Stem Cells Int 2015, 325652 (2015).","journal-title":"Stem Cells Int"},{"key":"425_CR97","volume":"15","author":"X Liu","year":"2017","unstructured":"Liu, X. et al. Comparative analysis of curative effect of bone marrow mesenchymal stem cell and bone marrow mononuclear cell transplantation for spastic cerebral palsy. J. Transl. Med 15, 48 (2017).","journal-title":"J. Transl. Med"},{"issue":"19","key":"425_CR98","doi-asserted-by":"crossref","first-page":"2259","DOI":"10.1089\/scd.2015.0074","volume":"24","author":"Mino Kang","year":"2015","unstructured":"Kang, M. et al. Involvement of Immune Responses in the Efficacy of Cord Blood Cell Therapy for Cerebral Palsy. Stem Cells Dev. 24, 1658\u20131671 (2015). Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25977995 .","journal-title":"Stem Cells and Development"},{"key":"425_CR99","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/j.jcyt.2015.02.010","volume":"17","author":"YA Romanov","year":"2015","unstructured":"Romanov, Y. A. et al. Human allogeneic AB0\/Rh-identical umbilical cord blood cells in the treatment of juvenile patients with cerebral palsy. Cytotherapy 17, 969\u2013978 (2015).","journal-title":"Cytotherapy"},{"key":"425_CR100","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1177\/0963689717729379","volume":"27","author":"L Huang","year":"2018","unstructured":"Huang, L. et al. A Randomized, placebo-controlled trial of human umbilical cord blood mesenchymal stem cell infusion for children with cerebral palsy. Cell Transpl. 27, 325\u2013334 (2018).","journal-title":"Cell Transpl."},{"key":"425_CR101","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.jcyt.2014.09.010","volume":"17","author":"X Wang","year":"2015","unstructured":"Wang, X. et al. Effect of umbilical cord mesenchymal stromal cells on motor functions of identical twins with cerebral palsy: pilot study on the correlation of efficacy and hereditary factors. Cytotherapy 17, 224\u2013231 (2015).","journal-title":"Cytotherapy"},{"key":"425_CR102","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1056\/NEJMra1005408","volume":"364","author":"J Neu","year":"2011","unstructured":"Neu, J. & Walker, W. A. Necrotizing Enterocolitis. N. Engl. J. Med. 364, 255\u2013264 (2011).","journal-title":"N. Engl. J. Med."},{"key":"425_CR103","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1089\/bfm.2013.0121","volume":"9","author":"K Herrmann","year":"2014","unstructured":"Herrmann, K. & Carroll, K. An exclusively human milk diet reduces necrotizing enterocolitis. Breast. Med. 9, 184\u2013190 (2014).","journal-title":"Breast. Med."},{"key":"425_CR104","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1016\/S0140-6736(16)00081-7","volume":"387","author":"BB Warner","year":"2016","unstructured":"Warner, B. B. et al. Gut bacteria dysbiosis and necrotising enterocolitis in very low birthweight infants: a prospective case-control study. Lancet 387, 1928\u20131936 (2016).","journal-title":"Lancet"},{"key":"425_CR105","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.siny.2018.08.006","volume":"23","author":"A Cuna","year":"2018","unstructured":"Cuna, A., George, L. & Sampath, V. Genetic predisposition to necrotizing enterocolitis in premature infants: Current knowledge, challenges, and future directions. Semin Fetal Neonatal Med. 23, 387\u2013393 (2018).","journal-title":"Semin Fetal Neonatal Med."},{"key":"425_CR106","doi-asserted-by":"crossref","first-page":"e1530","DOI":"10.1542\/peds.2014-3386","volume":"135","author":"V Sampath","year":"2015","unstructured":"Sampath, V. et al. SIGIRR genetic variants in premature infants with necrotizing enterocolitis. Pediatrics 135, e1530\u2013e1534 (2015).","journal-title":"Pediatrics"},{"key":"425_CR107","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.jcmgh.2018.04.001","volume":"6","author":"DJ Hackam","year":"2018","unstructured":"Hackam, D. J. & Sodhi, C. P. Toll-like receptor-mediated intestinal inflammatory imbalance in the pathogenesis of necrotizing enterocolitis. Cell Mol. Gastroenterol. Hepatol. 6, 229\u2013238.e1 (2018).","journal-title":"Cell Mol. Gastroenterol. Hepatol."},{"key":"425_CR108","doi-asserted-by":"crossref","first-page":"564089","DOI":"10.1155\/2011\/564089","volume":"2011","author":"LT Galindo","year":"2011","unstructured":"Galindo, L. T. et al. Mesenchymal stem cell therapy modulates the inflammatory response in experimental traumatic brain injury. Neurol. Res Int. 2011, 564089 (2011).","journal-title":"Neurol. Res Int."},{"key":"425_CR109","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2015\/602597","volume":"2015","author":"P Rowart","year":"2015","unstructured":"Rowart, P. et al. Mesenchymal stromal cell therapy in ischemia\/reperfusion injury. J. Immunol. Res. 2015, 1\u20138 (2015).","journal-title":"J. Immunol. Res."},{"key":"425_CR110","doi-asserted-by":"crossref","first-page":"119","DOI":"10.4103\/2394-8108.172881","volume":"1","author":"N Diaco","year":"2015","unstructured":"Diaco, N., Diamandis, Z. & Borlongan, C. Amniotic fluid-derived stem cells as an effective cell source for transplantation therapy in stroke. Brain Circ. 1, 119 (2015).","journal-title":"Brain Circ."},{"key":"425_CR111","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1016\/j.jpedsurg.2017.03.028","volume":"52","author":"CJ McCulloh","year":"2017","unstructured":"McCulloh, C. J., Olson, J. K., Zhou, Y., Wang, Y. & Besner, G. E. Stem cells and necrotizing enterocolitis: a direct comparison of the efficacy of multiple types of stem cells. J. Pediatr. Surg. 52, 999\u20131005 (2017).","journal-title":"J. Pediatr. Surg."},{"key":"425_CR112","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.jss.2017.03.026","volume":"214","author":"CJ McCulloh","year":"2017","unstructured":"McCulloh, C. J. et al. Evaluating the efficacy of different types of stem cells in preserving gut barrier function in necrotizing enterocolitis. J. Surg. Res. 214, 278\u2013285 (2017).","journal-title":"J. Surg. Res."},{"key":"425_CR113","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s00383-009-2504-x","volume":"26","author":"M Ghionzoli","year":"2010","unstructured":"Ghionzoli, M. et al. Amniotic fluid stem cell migration after intraperitoneal injection in pup rats: implication for therapy. Pediatr. Surg. Int. 26, 79\u201384 (2010).","journal-title":"Pediatr. Surg. Int."},{"key":"425_CR114","doi-asserted-by":"crossref","first-page":"057","DOI":"10.1055\/s-0033-1350059","volume":"24","author":"A Zani","year":"2013","unstructured":"Zani, A. et al. Amniotic fluid stem cells prevent development of ascites in a neonatal rat model of necrotizing enterocolitis. Eur. J. Pedia. Surg. 24, 057\u2013060 (2013).","journal-title":"Eur. J. Pedia. Surg."},{"key":"425_CR115","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1053\/j.sempedsurg.2017.11.011","volume":"27","author":"NA Drucker","year":"2018","unstructured":"Drucker, N. A. et al. Stem cell therapy in necrotizing enterocolitis: current state and future directions. Semin Pediatr. Surg. 27, 57\u201364 (2018).","journal-title":"Semin Pediatr. Surg."},{"key":"425_CR116","doi-asserted-by":"crossref","first-page":"e0211431","DOI":"10.1371\/journal.pone.0211431","volume":"14","author":"B Li","year":"2019","unstructured":"Li, B. et al. Bovine milk-derived exosomes enhance goblet cell activity and prevent the development of experimental necrotizing enterocolitis. PLoS ONE 14, e0211431 (2019).","journal-title":"PLoS ONE"},{"key":"425_CR117","volume":"6","author":"X Liu","year":"2015","unstructured":"Liu, X. et al. Rescue of neonatal cardiac dysfunction in mice by administration of cardiac progenitor cells in utero. Nat. Commun. 6, 8825 (2015).","journal-title":"Nat. Commun."},{"key":"425_CR118","unstructured":"Zhang, Z. et al. Pretreatment of cardiac stem cells with exosomes derived from mesenchymal stem cells enhances myocardial repair. J Am Heart Assoc. 5, e002856 (2016)."},{"key":"425_CR119","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1016\/j.jtcvs.2015.06.076","volume":"150","author":"S Tarui","year":"2015","unstructured":"Tarui, S. et al. Transcoronary infusion of cardiac progenitor cells in hypoplastic left heart syndrome: Three-year follow-up of the Transcoronary Infusion of Cardiac Progenitor Cells in Patients with Single-Ventricle Physiology (TICAP) trial. J. Thorac. Cardiovasc Surg. 150, 1198\u20131207 (2015).","journal-title":"J. Thorac. Cardiovasc Surg."},{"key":"425_CR120","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.ahj.2017.06.009","volume":"192","author":"S Kaushal","year":"2017","unstructured":"Kaushal, S. et al. Study design and rationale for ELPIS: A phase I\/IIb randomized pilot study of allogeneic human mesenchymal stem cell injection in patients with hypoplastic left heart syndrome. Am. Heart J. 192, 48\u201356 (2017).","journal-title":"Am. Heart J."},{"key":"425_CR121","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1007\/s00383-014-3576-9","volume":"30","author":"R Yuniartha","year":"2014","unstructured":"Yuniartha, R. et al. Therapeutic potential of mesenchymal stem cell transplantation in a nitrofen-induced congenital diaphragmatic hernia rat model. Pedia. Surg. Int. 30, 907\u2013914 (2014).","journal-title":"Pedia. Surg. Int."},{"key":"425_CR122","doi-asserted-by":"crossref","first-page":"e453","DOI":"10.1111\/aos.13154","volume":"95","author":"JD Wang","year":"2017","unstructured":"Wang, J.-D. et al. Human bone marrow mesenchymal stem cells for retinal vascular injury. Acta Ophthalmol. 95, e453\u2013e461 (2017).","journal-title":"Acta Ophthalmol."},{"key":"425_CR123","doi-asserted-by":"crossref","first-page":"391","DOI":"10.3727\/096368915X686887","volume":"24","author":"ZZ Wei","year":"2015","unstructured":"Wei, Z. Z. et al. Intranasal delivery of bone marrow mesenchymal stem cells improved neurovascular regeneration and rescued neuropsychiatric deficits after neonatal stroke in rats. Cell Transpl. 24, 391\u2013402 (2015).","journal-title":"Cell Transpl."},{"key":"425_CR124","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1002\/jnr.23954","volume":"95","author":"CT van Velthoven","year":"2017","unstructured":"van Velthoven, C. T. et al. Mesenchymal stem cells attenuate MRI-identifiable injury, protect white matter, and improve long-term functional outcomes after neonatal focal stroke in rats. J. Neurosci. Res. 95, 1225\u20131236 (2017).","journal-title":"J. Neurosci. Res."},{"key":"425_CR125","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1161\/STROKEAHA.111.000326","volume":"44","author":"CTJ Van Velthoven","year":"2013","unstructured":"Van Velthoven, C. T. J. et al. Mesenchymal stem cell transplantation attenuates brain injury after neonatal stroke. Stroke 44, 1426\u20131432 (2013).","journal-title":"Stroke"},{"key":"425_CR126","first-page":"1","volume":"2014","author":"CH Jeong","year":"2014","unstructured":"Jeong, C. H. et al. Mesenchymal stem cells expressing brain-derived neurotrophic factor enhance endogenous neurogenesis in an ischemic stroke model. Biomed. Res. Int. 2014, 1\u201310 (2014).","journal-title":"Biomed. Res. Int."},{"key":"425_CR127","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1089\/scd.2016.0329","volume":"26","author":"Y Zhu","year":"2017","unstructured":"Zhu, Y. et al. Human umbilical cord mesenchymal stromal cells improve survival and bacterial clearance in neonatal sepsis in rats. Stem Cells Dev. 26, 1054\u20131064 (2017).","journal-title":"Stem Cells Dev."},{"key":"425_CR128","unstructured":"Hamidian, Jahromi, S., Li, Y., Davies, J. E. Effect of tumor necrosis factor alpha dose and exposure time on tumor necrosis factor induced gene-6 activation by neonatal and adult mesenchymal stromal cells. Stem Cells Dev. 27, 44\u201354 (2018). Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/29121823 ."},{"key":"425_CR129","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1096\/fj.15-279679","volume":"30","author":"I Panfoli","year":"2016","unstructured":"Panfoli, I. et al. Exosomes from human mesenchymal stem cells conduct aerobic metabolism in term and preterm newborn infants. FASEB J. 30, 1416\u20131424 (2016).","journal-title":"FASEB J."},{"key":"425_CR130","first-page":"1","volume":"12","author":"P Montanucci","year":"2016","unstructured":"Montanucci, P. et al. Functional profiles of human umbilical cord-derived adult mesenchymal stem cells in obese\/diabetic versus healthy women. Curr. Diabetes Rev. 12, 1\u201312 (2016).","journal-title":"Curr. Diabetes Rev."},{"key":"425_CR131","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.molmed.2015.02.008","volume":"21","author":"L Turner","year":"2015","unstructured":"Turner, L. US stem cell clinics, patient safety, and the FDA. Trends Mol. Med. 21, 271\u2013273 (2015).","journal-title":"Trends Mol. Med."},{"key":"425_CR132","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1111\/j.1523-536X.2012.00527.x","volume":"39","author":"RJ Hodges","year":"2012","unstructured":"Hodges, R. J., Bardien, N. & Wallace, E. Acceptability of stem cell therapy by pregnant women. Birth 39, 91\u201397 (2012).","journal-title":"Birth"},{"key":"425_CR133","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1038\/pr.2017.249","volume":"83","author":"WS Park","year":"2018","unstructured":"Park, W. S., Ahn, S. Y., Sung, S. I., Ahn, J.-Y. & Chang, Y. S. Strategies to enhance paracrine potency of transplanted mesenchymal stem cells in intractable neonatal disorders. Pediatr. Res. 83, 214\u2013222 (2018).","journal-title":"Pediatr. Res."},{"key":"425_CR134","doi-asserted-by":"crossref","first-page":"344","DOI":"10.3181\/00379727-149-38804","volume":"149","author":"KV Honn","year":"1975","unstructured":"Honn, K. V., Singley, J. A. & Chavin, W. Fetal bovine serum: a multivariate standard. Exp. Biol. Med. 149, 344\u2013347 (1975).","journal-title":"Exp. Biol. Med."},{"key":"425_CR135","doi-asserted-by":"crossref","unstructured":"Oikonomopoulos, A. et al. Optimization of human mesenchymal stem cell manufacturing: the effects of animal\/xeno-free media. Sci Rep. 2015;5:16570.","DOI":"10.1038\/srep16570"},{"key":"425_CR136","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1186\/scrt477","volume":"5","author":"P Swamynathan","year":"2014","unstructured":"Swamynathan, P. et al. Are serum-free and xeno-free culture conditions ideal for large scale clinical grade expansion of Wharton\u2019s jelly derived mesenchymal stem cells? A comparative study. Stem Cell Res. Ther. 5, 88 (2014).","journal-title":"Stem Cell Res. Ther."},{"key":"425_CR137","unstructured":"Boregowda, S. V., Phinney, D. G. Quantifiable Metrics for Predicting MSC Therapeutic Efficacy. J Stem Cell Res Ther. 6, pii: 365 (2016). Available from: https:\/\/www.omicsonline.org\/open-access\/quantifiable-metrics-for-predicting-msc-therapeutic-efficacy-2157-7633-1000365.php?aid=82018 ."},{"key":"425_CR138","doi-asserted-by":"crossref","first-page":"36","DOI":"10.7150\/ijms.21666","volume":"15","author":"V Volarevic","year":"2018","unstructured":"Volarevic, V. et al. Ethical and safety issues of stem cell-based therapy. Int J. Med. Sci. 15, 36\u201345 (2018).","journal-title":"Int J. Med. Sci."},{"key":"425_CR139","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1016\/j.jcyt.2013.06.006","volume":"15","author":"A Borghesi","year":"2013","unstructured":"Borghesi, A. et al. Genomic alterations in human umbilical cord-derived mesenchymal stromal cells call for stringent quality control before any possible therapeutic approach. Cytotherapy 15, 1362\u20131373 (2013).","journal-title":"Cytotherapy"},{"key":"425_CR140","doi-asserted-by":"crossref","first-page":"2837","DOI":"10.3389\/fimmu.2018.02837","volume":"9","author":"JR Ferreira","year":"2018","unstructured":"Ferreira, J. R. et al. Mesenchymal stromal cell secretome: influencing therapeutic potential by cellular pre-conditioning. Front Immunol. 9, 2837 (2018).","journal-title":"Front Immunol."},{"key":"425_CR141","doi-asserted-by":"crossref","unstructured":"Kilpinen, L. et al. Extracellular membrane vesicles from umbilical cord blood-derived MSC protect against ischemic acute kidney injury, a feature that is lost after inflammatory conditioning. J Extracell vesicles 2013;2. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/24349659 .","DOI":"10.3402\/jev.v2i0.21927"},{"key":"425_CR142","doi-asserted-by":"crossref","first-page":"643","DOI":"10.5966\/sctm.2013-0196","volume":"3","author":"AI Hoch","year":"2014","unstructured":"Hoch, A. I. & Leach, J. K. Concise review: optimizing expansion of bone marrow mesenchymal stem\/stromal cells for clinical applications. Stem Cells Transl. Med. 3, 643\u2013652 (2014).","journal-title":"Stem Cells Transl. Med."},{"key":"425_CR143","first-page":"612","volume-title":"J. Clin. Pharm. Ther.","author":"N Krzy\u017caniak","year":"2016","unstructured":"Krzy\u017caniak, N., Paw\u0142owska, I. & Bajorek, B. Review of drug utilization patterns in NICUs worldwide. J. Clin. Pharm. Ther. 41, (612\u2013620 (2016)."},{"key":"425_CR144","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.bbi.2018.02.006","volume":"70","author":"J Herz","year":"2018","unstructured":"Herz, J. et al. Interaction between hypothermia and delayed mesenchymal stem cell therapy in neonatal hypoxic-ischemic brain injury. Brain Behav. Immun. 70, 118\u2013130 (2018).","journal-title":"Brain Behav. Immun."},{"issue":"11","key":"425_CR145","doi-asserted-by":"publisher","first-page":"1778","DOI":"10.1002\/stem.2891","volume":"36","author":"Desiree Perlee","year":"2018","unstructured":"Perlee D., et al. Intravenous infusion of human adipose mesenchymal stem cells modifies the host response to lipopolysaccharide in humans: a randomized, single-blind, parallel group, placebo controlled trial. Stem Cells 2018. https:\/\/doi.org\/10.1002\/stem.2891 .","journal-title":"STEM CELLS"},{"key":"425_CR146","first-page":"1","volume":"10","author":"SY Ahn","year":"2015","unstructured":"Ahn, S. Y. et al. Optimal route for mesenchymal stem cells transplantation after severe intraventricular hemorrhage in newborn rats. PLoS ONE 10, 1\u201314 (2015).","journal-title":"PLoS ONE"},{"key":"425_CR147","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.mcn.2015.03.019","volume":"68","author":"SH Cameron","year":"2015","unstructured":"Cameron, S. H. et al. Delayed post-treatment with bone marrow-derived mesenchymal stem cells is neurorestorative of striatal medium-spiny projection neurons and improves motor function after neonatal rat hypoxia-ischemia. Mol. Cell Neurosci. 68, 56\u201372 (2015).","journal-title":"Mol. Cell Neurosci."},{"key":"425_CR148","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.3727\/096368915X689640","volume":"25","author":"WS Park","year":"2016","unstructured":"Park, W. S. et al. Optimal timing of mesenchymal stem cell therapy for neonatal intraventricular hemorrhage. Cell Transpl. 25, 1131\u20131144 (2016).","journal-title":"Cell Transpl."},{"key":"425_CR149","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1007\/s10529-018-2546-z","volume":"40","author":"AB Ara\u00fajo","year":"2018","unstructured":"Ara\u00fajo, A. B. et al. Isolation of human mesenchymal stem cells from amnion, chorion, placental decidua and umbilical cord: comparison of four enzymatic protocols. Biotechnol. Lett. 40, 989\u2013998 (2018).","journal-title":"Biotechnol. Lett."}],"container-title":["Pediatric Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41390-019-0425-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41390-019-0425-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41390-019-0425-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T21:26:43Z","timestamp":1684618003000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41390-019-0425-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,14]]},"references-count":149,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,1]]}},"alternative-id":["425"],"URL":"https:\/\/doi.org\/10.1038\/s41390-019-0425-5","relation":{},"ISSN":["0031-3998","1530-0447"],"issn-type":[{"value":"0031-3998","type":"print"},{"value":"1530-0447","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5,14]]},"assertion":[{"value":"16 April 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 April 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 May 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"GB is a scientific founder and stock option holder in Scioto Biosciences. CN, RJ, BT, and VS have no financial or other conflicts.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}